• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射链激酶对急性心肌梗死患者的降压作用。

The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction.

作者信息

Lew A S, Laramee P, Cercek B, Shah P K, Ganz W

出版信息

Circulation. 1985 Dec;72(6):1321-6. doi: 10.1161/01.cir.72.6.1321.

DOI:10.1161/01.cir.72.6.1321
PMID:4064276
Abstract

We studied the hypotensive effect of a rapid intravenous infusion of high-dose streptokinase in 98 patients with an acute myocardial infarction. The systolic blood pressure fell from 132 +/- 20 (range 90 to 174) to 97 +/- 21 mm Hg (range 58 to 152) at 15 +/- 8 min (range 4 to 40) after the commencement of the streptokinase infusion (p less than .001). A fall in diastolic blood pressure from 80 +/- 16 (range 51 to 105) to 61 +/- 15 mm Hg (range 32 to 92) accompanied the fall in systolic pressure (p less than .001). The fall in blood pressure was associated with an increase in heart rate (73 +/- 14 to 78 +/- 17 beats/min, p less than .001), preceded the appearance of clinical signs of reperfusion by 37 +/- 38 min and was similar in magnitude and timing in patients with anterior and inferior infarction. There were direct relationships between the rate of infusion of streptokinase and both the magnitude (r = .49, p less than .001) and the rate of fall of systolic blood pressure (r = .67, p less than .001) as well as both the magnitude and rate of fall of diastolic blood pressure. In most patients, the fall in blood pressure was transient (9 +/- 6 min, range = 2 to 30) and easily managed by slowing or stopping the infusion, placing the patient in the Trendelenburg position, or by administering an infusion of low-dose norepinephrine or dopamine. However, in four patients with severe left ventricular dysfunction, severe hypotension persisted for more than 60 min.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了大剂量链激酶快速静脉输注对98例急性心肌梗死患者的降压作用。链激酶输注开始后15±8分钟(范围4至40分钟),收缩压从132±20(范围90至174)降至97±21毫米汞柱(范围58至152)(p<0.001)。舒张压从80±16(范围51至105)降至61±15毫米汞柱(范围32至92),伴随收缩压下降(p<0.001)。血压下降与心率增加有关(从73±14次/分钟增至78±17次/分钟,p<0.001),在再灌注临床体征出现前37±38分钟出现,且在前壁和下壁梗死患者中,其幅度和时间相似。链激酶输注速率与收缩压下降幅度(r = 0.49,p<0.001)、收缩压下降速率(r = 0.67,p<0.001)以及舒张压下降幅度和速率均呈直接关系。在大多数患者中,血压下降是短暂的(9±6分钟,范围2至30分钟),通过减慢或停止输注、将患者置于头低脚高位或输注低剂量去甲肾上腺素或多巴胺很容易控制。然而,4例严重左心室功能不全患者出现严重低血压持续超过60分钟。(摘要截短于250字)

相似文献

1
The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction.静脉注射链激酶对急性心肌梗死患者的降压作用。
Circulation. 1985 Dec;72(6):1321-6. doi: 10.1161/01.cir.72.6.1321.
2
[Behavior of arterial pressure during administration of intravenous streptokinase, in patients with acute myocardial infarct].
Rev Port Cardiol. 1989 Apr;8(4):269-73.
3
[Arterial blood pressure behavior during the administration of intravenous streptokinase, in patients with acute myocardial infarction].[急性心肌梗死患者静脉注射链激酶期间的动脉血压行为]
Rev Port Cardiol. 2001 May;20 Suppl 5:V-147-52.
4
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.急性心肌梗死静脉注射茴香酰化纤溶酶原链激酶激活剂复合物(APSAC)的多中心再灌注试验:与冠状动脉内链激酶的对照比较
J Am Coll Cardiol. 1988 Jun;11(6):1153-63. doi: 10.1016/0735-1097(88)90276-8.
5
The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.含链激酶制剂溶栓治疗急性心肌梗死后低血压的发生率及机制——与治疗前链激酶抵抗无关
Eur Heart J. 1993 Jun;14(6):819-25. doi: 10.1093/eurheartj/14.6.819.
6
The effects of the rate of intravenous infusion of streptokinase and the duration of symptoms on the time interval to reperfusion in patients with acute myocardial infarction.链激酶静脉输注速率及症状持续时间对急性心肌梗死患者再灌注时间间隔的影响。
Circulation. 1985 Nov;72(5):1053-8. doi: 10.1161/01.cir.72.5.1053.
7
Streptokinase-induced transient aggravation of myocardial injury.链激酶诱导的心肌损伤短暂加重。
Int J Cardiol. 1995 Jun 30;50(2):107-16. doi: 10.1016/0167-5273(95)93679-m.
8
[On the possibility of accelerating thrombolytic therapy in the acute phase of myocardial infarction: efficacy of and tolerance to the infusion of 1.5 million units of streptokinase in 30 minutes].
G Ital Cardiol. 1989 Jan;19(1):53-8.
9
Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy.
Am J Cardiol. 1993 May 1;71(12):1021-4. doi: 10.1016/0002-9149(93)90566-u.
10
Effect of thrombolytic therapy on exercise response during early recovery from acute myocardial infarction: a placebo controlled study.溶栓治疗对急性心肌梗死早期恢复过程中运动反应的影响:一项安慰剂对照研究。
Eur Heart J. 1992 Jan;13(1):33-8. doi: 10.1093/oxfordjournals.eurheartj.a060044.

引用本文的文献

1
Effect of drug interventions on cerebral hemodynamics in ischemic stroke patients.药物干预对缺血性脑卒中患者脑血流动力学的影响。
J Cereb Blood Flow Metab. 2022 Mar;42(3):471-485. doi: 10.1177/0271678X211058261. Epub 2021 Nov 5.
2
Pathophysiology of streptokinase-induced hypotension in acute myocardial infarction: a systematic review of clinical evidence.急性心肌梗死中链激酶诱导低血压的病理生理学:临床证据的系统评价
Arch Med Sci Atheroscler Dis. 2021 Apr 16;6:e85-e94. doi: 10.5114/amsad.2021.105410. eCollection 2021.
3
Higher incidence of hypotension episodes in women during the sub-acute phase of ST elevation myocardial infarction and relationship to covariates.
ST段抬高型心肌梗死亚急性期女性低血压发作的发生率较高及其与协变量的关系。
PLoS One. 2017 Mar 9;12(3):e0173699. doi: 10.1371/journal.pone.0173699. eCollection 2017.
4
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.监测重组链激酶在急性心肌梗死中不良反应的药物警戒计划。
BMC Clin Pharmacol. 2005 Nov 2;5:5. doi: 10.1186/1472-6904-5-5.
5
Pharmacologic reperfusion therapy for acute myocardial infarction.急性心肌梗死的药物再灌注治疗
J Thromb Thrombolysis. 2002 Dec;14(3):179-96. doi: 10.1023/a:1025050208649.
6
Comparative tolerability profiles of thrombolytic agents. A review.溶栓药物的耐受性比较概况。综述。
Drug Saf. 1993 Jan;8(1):19-29. doi: 10.2165/00002018-199308010-00004.
7
Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.急性心肌梗死静脉输注链激酶后发生急性肾衰竭。
West J Med. 1993 Apr;158(4):406-9.
8
Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.链激酶。老年患者急性心肌梗死中其药理学及治疗效果的综述
Drugs Aging. 1994 Jan;4(1):63-86. doi: 10.2165/00002512-199404010-00007.
9
Pharmacokinetic optimisation of the treatment of embolic disorders.栓塞性疾病治疗的药代动力学优化
Clin Pharmacokinet. 1995 Jan;28(1):67-92. doi: 10.2165/00003088-199528010-00006.
10
Drug interactions with thrombolytic agents. Current perspectives.与溶栓药物的药物相互作用。当前观点
Clin Pharmacokinet. 1995 Apr;28(4):315-26. doi: 10.2165/00003088-199528040-00004.